|
US3565924A
(en)
|
1968-07-01 |
1971-02-23 |
Wisconsin Alumni Res Found |
25-hydroxycholfcalciferol
|
|
US3880894A
(en)
|
1974-05-24 |
1975-04-29 |
Wisconsin Alumni Res Found |
1,25-Dihydroxyergocalciferol
|
|
US4004003A
(en)
|
1974-08-28 |
1977-01-18 |
The Upjohn Company |
25-Hydroxycalciferol compounds for treatment of steroid-induced osteoporosis
|
|
US4230701A
(en)
|
1979-03-21 |
1980-10-28 |
Hoffmann-La Roche Inc. |
Administration of biologically active vitamin D3 and vitamin D2 materials
|
|
US4335120A
(en)
|
1979-03-21 |
1982-06-15 |
Hoffmann-La Roche Inc. |
Administration of biologically active vitamin D3 and vitamin D2 materials
|
|
US4721613A
(en)
|
1982-12-13 |
1988-01-26 |
Alza Corporation |
Delivery system comprising means for shielding a multiplicity of reservoirs in selected environment of use
|
|
JPS59155309A
(ja)
|
1983-02-22 |
1984-09-04 |
Teijin Ltd |
活性型ビタミンｄ↓３類組成物
|
|
US4508651A
(en)
*
|
1983-03-21 |
1985-04-02 |
Hoffmann-La Roche Inc. |
Synthesis of 1α,25-dihydroxyergocalciferol
|
|
US4684524A
(en)
|
1984-03-19 |
1987-08-04 |
Alza Corporation |
Rate controlled dispenser for administering beneficial agent
|
|
US4555364A
(en)
|
1984-11-01 |
1985-11-26 |
Wisconsin Alumni Research Foundation |
Method for preparing 1-hydroxyvitamin D compounds
|
|
US4695591A
(en)
|
1985-03-29 |
1987-09-22 |
Schering Corporation |
Controlled release dosage forms comprising hydroxypropylmethylcellulose
|
|
US4668517A
(en)
|
1985-04-04 |
1987-05-26 |
Norwich Eaton Pharmaceuticals, Inc. |
Furazolidone dosage form
|
|
EP0207638B1
(en)
|
1985-06-04 |
1990-12-19 |
Teijin Limited |
Sustained-release pharmaceutical preparation
|
|
JPS61293911A
(ja)
|
1985-06-24 |
1986-12-24 |
Teisan Seiyaku Kk |
徐放化製剤
|
|
US5104864A
(en)
|
1988-08-02 |
1992-04-14 |
Bone Care International, Inc. |
Method for treating and preventing loss of bone mass
|
|
US5869473A
(en)
|
1988-08-02 |
1999-02-09 |
Bone Care International, Inc. |
Method for treating and preventing hyperparathyroidism
|
|
US5602116A
(en)
*
|
1988-08-02 |
1997-02-11 |
Bone Care International, Inc. |
Method for treating and preventing secondary hyperparathyroidism
|
|
JP2893191B2
(ja)
|
1988-11-08 |
1999-05-17 |
武田薬品工業株式会社 |
放出制御性マトリックス剤
|
|
US5026559A
(en)
|
1989-04-03 |
1991-06-25 |
Kinaform Technology, Inc. |
Sustained-release pharmaceutical preparation
|
|
GB9004544D0
(en)
|
1990-03-01 |
1990-04-25 |
Leo Pharm Prod Ltd |
Novel treatment ii
|
|
JP2845342B2
(ja)
|
1990-04-28 |
1999-01-13 |
大正製薬株式会社 |
ビタミンｄ▲下３▼誘導体含有固形製剤組成物
|
|
JP2893140B2
(ja)
|
1990-11-30 |
1999-05-17 |
エスエス製薬株式会社 |
安定なビタミンｄ製剤
|
|
DE69214704T2
(de)
|
1991-04-09 |
1997-04-17 |
Takeda Chemical Industries Ltd |
Stabilisiertes Vitamin D Arzneimittel
|
|
US5693615A
(en)
|
1991-06-05 |
1997-12-02 |
The Procter & Gamble Company |
Therapeutic compositions for osteoinduction
|
|
US5160742A
(en)
|
1991-12-31 |
1992-11-03 |
Abbott Laboratories |
System for delivering an active substance for sustained release
|
|
JP3722832B2
(ja)
|
1992-06-22 |
2005-11-30 |
ルーナー、コーポレーション |
経口用１α−ヒドロキシプレビタミンＤ
|
|
US5795882A
(en)
|
1992-06-22 |
1998-08-18 |
Bone Care International, Inc. |
Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
|
|
US5354743A
(en)
|
1992-09-15 |
1994-10-11 |
Thys Jacobs Susan |
Method for the treatment of premenstrual syndrome with vitamin D
|
|
JPH07242550A
(ja)
|
1994-03-02 |
1995-09-19 |
Teijin Ltd |
二次性副甲状腺機能亢進症治療剤
|
|
IL110117A0
(en)
|
1994-06-24 |
1994-10-07 |
Univ Ben Gurion |
Pharmaceutical compositions comprising vitamin-d analogs
|
|
JPH0892098A
(ja)
|
1994-09-27 |
1996-04-09 |
Teijin Ltd |
肺結核治療剤
|
|
US20020183288A1
(en)
*
|
1995-04-03 |
2002-12-05 |
Bone Care International, Inc. |
Method for treating and preventing hyperparathyroidism
|
|
US6376479B1
(en)
|
1995-04-03 |
2002-04-23 |
Bone Care International, Inc. |
Method for treating and preventing hyperparathyroidism
|
|
US20040043971A1
(en)
*
|
1995-04-03 |
2004-03-04 |
Bone Care International, Inc. |
Method of treating and preventing hyperparathyroidism with active vitamin D analogs
|
|
WO1997011053A1
(en)
|
1995-09-21 |
1997-03-27 |
Wisconsin Alumni Research Foundation |
Calcitriol derivatives and their uses
|
|
DE19549243A1
(de)
|
1995-12-21 |
1997-06-26 |
Schering Ag |
Pharmazeutische Präparate enthaltend Clathrate von Cyclodextrinen und nichtnatürliche Vitamin D-Analoga
|
|
EP0949927B1
(en)
|
1996-08-26 |
2002-10-16 |
Takeda Chemical Industries, Ltd. |
Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
|
|
ES2565163T3
(es)
|
1996-10-28 |
2016-03-31 |
General Mills, Inc. |
Imbibición y encapsulación de partículas de liberación controlada y producto encapsulado
|
|
JPH10158171A
(ja)
|
1996-12-02 |
1998-06-16 |
Kita:Kk |
ビタミンｄ化合物を配合した眼内投与剤
|
|
US20020076442A1
(en)
|
1997-09-02 |
2002-06-20 |
Martin Burke |
Vitamin d3 analog loaded polymer formulations for cancer and neurodegenerative disorders
|
|
US6139875A
(en)
|
1998-09-29 |
2000-10-31 |
Eastman Chemical Company |
Aqueous enteric coating composition and low gastric permeability enteric coating
|
|
DE69940821D1
(de)
|
1998-10-09 |
2009-06-10 |
Gen Mills Inc |
Verkapselung empfindlicher flüssiger komponenten in eine matrix zur gewinnung diskreter lagerbeständiger partikel
|
|
AU765909C
(en)
|
1998-12-17 |
2004-09-23 |
Alza Corporation |
Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
|
|
US6342249B1
(en)
|
1998-12-23 |
2002-01-29 |
Alza Corporation |
Controlled release liquid active agent formulation dosage forms
|
|
US6432936B1
(en)
|
1999-01-20 |
2002-08-13 |
Wisconsin Alumni Research Foundation |
Crystalline 1α-hydroxyvitamin D2 and method of purification thereof
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
CA2366586C
(en)
|
1999-04-01 |
2004-06-22 |
Johns Hopkins University |
Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1.alpha., 25-dihydroxy vitamin d3
|
|
WO2000072831A1
(en)
|
1999-05-27 |
2000-12-07 |
Drugtech Corporation |
Nutritional formulations
|
|
US6051567A
(en)
|
1999-08-02 |
2000-04-18 |
Abbott Laboratories |
Low oxygen content compositions of 1α, 25-dihydroxycholecalciferol
|
|
US6274169B1
(en)
|
1999-08-02 |
2001-08-14 |
Abbott Laboratories |
Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol
|
|
IL153378A0
(en)
|
2000-07-18 |
2003-07-06 |
Bone Care Internat Inc |
STABILIZED 1alpha-HYDROXY VITAMIN D
|
|
US6524615B2
(en)
*
|
2001-02-21 |
2003-02-25 |
Kos Pharmaceuticals, Incorporated |
Controlled release pharmaceutical composition
|
|
ES2283593T3
(es)
|
2001-10-12 |
2007-11-01 |
Johns Hopkins University |
Analogos de oxima poco calcemicos de 1alfa,25-dihidroxi vitamina d3.
|
|
US7056655B2
(en)
|
2001-11-02 |
2006-06-06 |
Scantibodies Laboratory, Inc. |
Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
|
|
ITMI20012366A1
(it)
|
2001-11-09 |
2003-05-09 |
Farmatron Ltd |
Sistemi terapeutici stabilizzati a rilascio immediato e/o modificato per la somministrazione orale di principi attivi e/o eccipienti e/o ali
|
|
US20030191093A1
(en)
|
2001-12-03 |
2003-10-09 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
|
ATE543796T1
(de)
|
2002-06-13 |
2012-02-15 |
Univ Johns Hopkins |
24-sulfoximine vitamin d3 derivate
|
|
AU2002368245A1
(en)
|
2002-09-26 |
2004-04-19 |
Young-Kweon Choi |
Matrix type patch for transdermal administration of vitamin d analog and the use thereof
|
|
US20050101576A1
(en)
|
2003-11-06 |
2005-05-12 |
Novacea, Inc. |
Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes
|
|
JP2004175750A
(ja)
|
2002-11-28 |
2004-06-24 |
Kose Corp |
皮膚障害抑制剤、皮膚障害改善剤、及びそれらを含有する皮膚外用剤
|
|
DE10393906T5
(de)
|
2002-12-16 |
2006-01-12 |
Teva Pharmaceutical Industries Ltd. |
Verfahren zur Erhöhung der Bioverfügbarkeit von Alendronat oder einem anderen Bisphosphonat durch Verabreichen einer Vordosis eines Vitamin D-Derivats
|
|
US20050020546A1
(en)
*
|
2003-06-11 |
2005-01-27 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
|
US20050124591A1
(en)
|
2003-07-29 |
2005-06-09 |
Jin Tian |
Use of vitamin Ds to treat kidney disease
|
|
US20050148557A1
(en)
|
2003-07-29 |
2005-07-07 |
Jin Tian |
Use of Vitamin Ds to treat kidney disease
|
|
US20050209203A1
(en)
*
|
2003-07-30 |
2005-09-22 |
Jin Tian |
Use of vitamin Ds or vitamin D analogs to treat cardiovascular disease
|
|
US20060171983A1
(en)
*
|
2003-07-30 |
2006-08-03 |
Jin Tian |
Use of Vitamin D receptor activators or Vitamin D analogs to treat cardiovascular disease
|
|
WO2005123120A1
(en)
|
2004-06-16 |
2005-12-29 |
Smart Drug Systems Inc. |
Sustained release vaccine composition
|
|
US8318210B2
(en)
|
2005-02-28 |
2012-11-27 |
Neos Therapeutics, Lp |
Compositions and methods of making sustained release liquid formulations
|
|
EP1945185B1
(en)
|
2005-10-12 |
2016-02-03 |
Proventiv Therapeutics, LLC |
Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency
|
|
SI1993559T1
(sl)
|
2006-02-03 |
2017-01-31 |
Opko Renal, Llc |
Zdravljenje nezadostnosti in pomanjkanja vitamina D s 25-hidroksivitaminon D2 in 25-hidroksivitaminom D3
|
|
DK3357496T3
(da)
|
2006-06-21 |
2020-05-11 |
Opko Ireland Global Holdings Ltd |
Terapi ved brug af vitamin d-repletteringsmiddel og vitamin d-hormonsubstitutionsmiddel
|
|
CA2684778C
(en)
*
|
2007-04-25 |
2017-09-05 |
Cytochroma Inc. |
Methods and compounds for vitamin d therapy
|
|
PT2148661E
(pt)
|
2007-04-25 |
2013-03-06 |
Proventiv Therapeutics Llc |
Composições orais de libertação controlada compreendendo um composto de vitamina d e veículo ceroso
|
|
ES3047207T3
(en)
|
2007-04-25 |
2025-12-03 |
Opko Renal Llc |
Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
|
|
PL2321273T3
(pl)
|
2008-07-24 |
2015-05-29 |
Wisconsin Alumni Res Found |
Podawanie 25-hydroksy-witaminy D3 raz w tygodniu w celu utrzymania podwyższonego stężenia we krwi w stanie równowagi farmakokinetycznej
|